Combined chemo- and radiotherapy vs. radiotherapy alone in the treatment of primary, nonresectable adenocarcinoma of the rectum

International Journal of Radiation Oncology Biology Physics

Volumn 50, Issue 2, 2001, Pages 427-434

  Frykholm, Gunilla Jansson ^a   Påhlman, Lars ^b   Glimelius, Bengt ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Chemoradiotherapy; Nonresectable; Radiotherapy; Randomized trial; Rectal cancer

Indexed keywords

CHEMOTHERAPY; PATIENT MONITORING; RADIOTHERAPY; SURGERY; TOXICITY; TUMORS;

RECTAL CANCER;

ONCOLOGY;

FLUOROURACIL; FOLINIC ACID; METHOTREXATE; ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; BOLUS INJECTION; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; FEMALE; HISTOLOGY; HUMAN; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; MORTALITY; MUCOSA INFLAMMATION; PREOPERATIVE RADIOTHERAPY; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RECTUM CARCINOMA; RECURRENCE RISK; SKIN TOXICITY; SURVIVAL; TECHNIQUE; TREATMENT OUTCOME; TUMOR VOLUME; ADENOCARCINOMA; DISEASE FREE SURVIVAL; DRUG ADMINISTRATION; MIDDLE AGED; MULTICENTER STUDY; MULTIMODALITY CANCER THERAPY; RADIOTHERAPY; RANDOMIZED CONTROLLED TRIAL; RECTUM TUMOR; SURVIVAL RATE;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; DRUG ADMINISTRATION SCHEDULE; FEMALE; FLUOROURACIL; HUMANS; LEUCOVORIN; MALE; METHOTREXATE; MIDDLE AGED; RADIOTHERAPY; RECTAL NEOPLASMS; SURVIVAL RATE;

EID: 17344384995     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(01)01479-1     Document Type: Article

References (43)

1. Durdey P., Williams N.S. The effect of malignant and inflammatory fixation of rectal carcinoma on prognosis after rectal excision. Br J Surg. 71:1984;787-790.
2. Påhlman L., Glimelius B., Ginman C., et al. Preoperative irradiation of primarily unresectable adenocarcinoma of the rectum and rectosigmoid. Acta Radiol Oncol. 24:1985;35-40.
3. Dahlberg M., Glimelius B., Pahlman L. Changed strategy in the treatment of rectal cancer improves survival Results from a single unit series . Br J Surg. 86:1999;379-384.
4. Bjerkeset T., Dahl O. Irradiation and surgery for primarily inoperable rectal adenocarcinoma. Dis Colon Rectum. 23:1980;298-303.
5. Tobin R., Mohiuddin M., Marks G. Preoperative irradiation for cancer of the rectum with extrarectal fixation. Int J Radiat Oncol Biol Phys. 21:1991;1127-1132.
6. Kopelson G. Long-time survivors after preoperative pelvic radiation therapy for locally unresectable rectal and sigmoid carcinoma. Dis Colon Rectum. 25:1982;644-647.
7. Dosoretz D.E., Gunderson L.L., Hedberg S., et al. Preoperative irradiation for unresectable rectal and rectosigmoid carcinomas. Cancer. 52:1989;814-818.
8. Overgaard M., Overgaard J., Sell A. Dose-response relationship for radiation therapy of recurrent, residual, and primarily inoperable colorectal cancer. Radiother Oncol. 1:1984;217-222.
9. Mella O., Dahl O., Horn A., et al. Radiotherapy and resection for apparently inoperable rectal carcinoma. Dis Colon Rectum. 27:1984;663-668.
10. Steel G.G. The search for therapeutic gain in the combination of radiotherapy and chemotherapy. Radiother Oncol. 11:1988;31-53.
11. von der Maase H. Experimental studies on interactions of radiation and cancer chemotherapeutic drugs in normal tissues and a solid tumour. Radiother Oncol 1986;7:47-68.
12. Byfield J., Calabro-Jones P., Klisak I., et al. Pharmacologic requirements for obtaining sensitization of human tumor cells in vitro to combined 5-fluorouracil or ftorafur and x-rays. Int J Radiat Oncol Biol Phys. 8:1982;1923-1933.
13. Moertel C.G., Childs D.S. Jr, Reitemeier R.J., et al. Combined 5-fluorouracil and supervoltage radiation therapy of locally unresectable gastrointestinal cancer. Lancet. 2:1969;865-867.
14. Rominger CJ, Gelber RD, Gunderson LL; et al. Radiation therapy alone or in combination with chemotherapy in the treatment of residual or inoperable carcinoma of the rectum and rectosigmoid or pelvic recurrence following colorectal surgery. Radiation Therapy Oncology Group study (76-16). Am J Clin Oncol 1985;8:118-127.
15. Overgaard M., Bertelsen K., Dalmark M., et al. A randomized feasibility study evaluating the effect of radiotherapy alone or combined with 5-fluorouracil in the treatment of locally recurrent or inoperable colorectal carcinoma. Acta Oncol. 32:1993;547-553.
16. Minsky B.D., Cohen A.M., Kemeny N., et al. The efficacy of preoperative 5-fluorouracil, high dose leucovorin and sequential radiation therapy for unresectable rectal cancer. Cancer. 71:1993;3486-3492.
17. Marsh R. de W., Chu N.M., Vauthey J.N., et al. Preoperative treatment of patients with locally advanced unresectable rectal adenocarcinoma utilizing continuous chronobiologically shaped 5-fluorouracil infusion and radiation therapy. Cancer. 78:1996;217-225.
18. De La Torre A., Ramos S., Valcárcel F., et al. Phase II study of radiochemotherapy with UFT and low-dose oral leucovorin in patients with unresectable rectal cancer. Int J Radiat Oncol Biol Phys. 45:1999;629-634.
19. Videtic G.M.M., Fisher B.J., Perera F.E., et al. Preoperative radiation with concurrent 5-fluorouracil continuous infusion for locally advanced unresectable rectal cancer. Int J Radiat Oncol Biol Phys. 42:1998;319-324.
20. Frykholm G., Glimelius B., Påhlman L. Preoperative irradiation with and without chemotherapy (MFL) in the treatment of primary non-resectable adenocarcinoma of the rectum. Results from two consecutive studies. Eur J Cancer Clin Oncol. 25:1989;1535-1541.
21. ICRU report 50. Prescribing, recording and reporting photon beam therapy. International Commission on Radiation Units and Measurements. Bethesda, MD, 1993.
22. nd rev. Berlin, Germany: Springer-Verlag, 1992.
23. WHO. Handbook for reporting results of cancer treatment. WHO offset publication no. 48. Geneva, 1979.
24. Frykholm G., Nyman R., Glimelius B., et al. Non-resectable adenocarcinoma of the rectum assessed by MR imaging before and after chemotherapy and irradiation. Acta Radiol. 33:1992;447-452.
25. Biochemical modulation of 5-fluorouracil A randomized comparison of sequential methotrexate, 5-fluorouracil and leucovorin versus sequential 5-fluorouracil and leucovorin in patients with advanced symptomatic colorectal cancer . Ann Oncol. 4:1993;235-241.
26. Peto R., Pike M., Armitage P., et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer. 35:1977;1-39.
27. Danjoux C.E., Gelber R.D., Catton G.E., et al. Combination chemoradiotherapy for residual, recurrent or inoperable carcinoma of the rectum E.C.O.G study (EST 3276) . Int J Radiat Oncol Biol Phys. 11:1985;765-771.
28. Minsky B.D., Kemeny M., Cohen A.M., et al. Preoperative high dose leucovorin/5-fluorouracil and radiation therapy for unresectable rectal cancer. Cancer. 67:1991;2859-2866.
29. Kirk J., Gray W.N., Watson E.R. Cumulative radiation effect. Part I: Fractionated treatment regimes . Clin Radiol. 22:1971;145-155.
30. Turesson I., Notter G. The influence of fraction size in radiotherapy on the late normal tissue reaction - I & II. Int J Radiat Oncol Biol Phys. 10:1984;593-606.
31. Fowler J.F. The linear-quadratic formula and progress in fractionated radiotherapy. Br J Radiol. 62:1989;679-694.
32. Prolongation of the disease-free interval in surgically treated rectal carcinoma. New Engl J Med. 312:1985;1464-1472.
33. Krook J.E., Moertel C.G., Gunderson L.L., et al. Effective surgical adjuvant therapy for high-risk rectal cancer. New Engl J Med. 324:1991;709-715.
34. Fisher B., Wolmark N., Rockette H., et al. Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer Results from NSABP Protocol R-01 . J Natl Cancer Inst. 80:1988;21-29.
35. Tveit K.M., Guldvog I., Hagen S., et al. Randomized controlled trial of postoperative radiotherapy and short-term time-scheduled 5-fluorouracil against surgery alone in the treatment of Dukes B and C rectal cancer. Br J Surg. 84:1997;1130-1135.
36. O'Connell M.J., Martenson J.A., Wieand H.S., et al. Improving adjuvant therapy for rectal cancer by combining protracted infusion fluorouracil with radiation therapy after curative surgery. N Engl J Med. 331:1994;502-507.
37. NIH Consensus Conference. Adjuvant therapy for patients with colon and rectal cancer. JAMA 1990;264:1444-1450.
38. Gunderson L.L. Indications for and results of combined modality treatment of colorectal cancer. Acta Oncol. 38:1999;7-21.
39. Glimelius B., Pahlman L. Perioperative radiotherapy in rectal cancer. Acta Oncol. 38:1999;23-32.
40. Gunderson L.L., Nelson H., Martenson J.A., et al. Locally advanced primary colorectal cancer Intraoperative electron and external beam irradiation ± 5-FU . Int J Radiat Oncol Biol Phys. 37:1997;601-614.
41. Lanciano R.M., Calkins A.R., Wolkov H.B., et al. A phase I/II study of intraoperative radiotherapy in advanced unresectable or recurrent carcinoma of the rectum A Radiation Therapy Oncology Group (RTOG) study . J Surg Oncol. 53:1993;20-29.
42. Tveit K.M., Wiig J.N., Olsen D.R., et al. Combined modality treatment including intraoperative radiotherapy in locally advanced and recurrent rectal cancer. Radiother Oncol. 44:1997;277-282.
43. Willet C.G., Shellito P.C., Tepper J.E., et al. Intraoperative electron beam radiation therapy for primary, locally advanced rectal and rectosigmoid carcinoma. J Clin Oncol. 9:1991;843-847.